In recent years, the translation of genomic discoveries into mainstream medical practice and public health has gained momentum, facilitated by the advent of new technologies. However, there are often major discrepancies in the pace of implementation of genomic medicine between developed and developing/resource-limited countries. The main reason does not only lie in the limitation of resources but also in the slow pace of adoption of the new findings and the poor understanding of the potential that this new discipline offers to rationalize medical diagnosis and treatment. Here, we present and critically discuss examples from the successful implementation of genomic medicine in resource-limited countries, focusing on pharmacogenomics, genome ...
Abstract Background The benefits of genomics and biot...
The decade following the completion of the Human Genome Project has been marked by divergent claims ...
AbstractThe differences between countries in national income, growth, human development and many oth...
In recent years, the translation of genomic discoveries into mainstream medical practice and public ...
Even though the translation of genomic discoveries into clinic and public health has gained momentum...
The finished version of the human genome sequence was completed in 2003, and this event initiated a ...
Around the world, innovative genomic-medicine programs capitalize on singular capabilities arising f...
Advances in high-throughput genomic technologies and the growing number of clinically useful results...
In this paper, we advance the extant health technology innovation frames on global personalized medi...
The notion that developing countries must wait for the developed world to make advances in science a...
Genomics has facilitated the identification of a large number of genetic variants that are causal an...
Around the world, innovative genomic-medicine programs capitalize on singular capabilities arising f...
Around the world, innovative genomic-medicine programs capitalize on singular capabilities arising f...
Low and middle-income countries have become a site of increasing research interest and investment wi...
Advances in precision medicine depend on the quantity and quality of available genomic information. ...
Abstract Background The benefits of genomics and biot...
The decade following the completion of the Human Genome Project has been marked by divergent claims ...
AbstractThe differences between countries in national income, growth, human development and many oth...
In recent years, the translation of genomic discoveries into mainstream medical practice and public ...
Even though the translation of genomic discoveries into clinic and public health has gained momentum...
The finished version of the human genome sequence was completed in 2003, and this event initiated a ...
Around the world, innovative genomic-medicine programs capitalize on singular capabilities arising f...
Advances in high-throughput genomic technologies and the growing number of clinically useful results...
In this paper, we advance the extant health technology innovation frames on global personalized medi...
The notion that developing countries must wait for the developed world to make advances in science a...
Genomics has facilitated the identification of a large number of genetic variants that are causal an...
Around the world, innovative genomic-medicine programs capitalize on singular capabilities arising f...
Around the world, innovative genomic-medicine programs capitalize on singular capabilities arising f...
Low and middle-income countries have become a site of increasing research interest and investment wi...
Advances in precision medicine depend on the quantity and quality of available genomic information. ...
Abstract Background The benefits of genomics and biot...
The decade following the completion of the Human Genome Project has been marked by divergent claims ...
AbstractThe differences between countries in national income, growth, human development and many oth...